Pathfree Expansion LLC Announces Innovative Investment Opportunity For Accredited Investors
PathFree Expansion LLC offers Reg D 506(c) Security convertible common units to accredited investors to invest in PathFree Technologies Corporation. Investors are entitled to 50% of PathFree Technologies Corporation's profit annually for 5 years. PathFree Expansion LLC seeks $10 million in capital to manufacture the PathFree AiCart.
- Los Angeles-Long Beach, CA (1888PressRelease) May 12, 2023 - Join the Revolution of Medical Device Innovation with PathFree Expansion LLC
Attention Accredited Investors! Are you ready to be a part of something exceptional? PathFree Expansion LLC is offering a unique opportunity to revolutionize the healthcare industry with cutting-edge medical devices. With multiple patented devices, we are set to change the landscape of healthcare and offer healthcare professionals safer and more efficient alternatives to existing devices.
Reg D 506(c) Security Offering Convertible Common Units
As an accredited investor, you can participate in our company's growth and profitability for a period of 5 years through the Reg D 506(c) Security offering convertible common units. Our aim is to expand our manufacturing and distribution capabilities to bring our innovative devices to the global market.
Investing in the Future of Medical Innovation
Join us in leading the charge in medical innovation. Our devices address unmet medical needs and provide healthcare professionals with cutting-edge technology to improve patient outcomes.
Profit-Sharing Returns with the Potential for Growth
Investors in PathFree Expansion LLC will receive 50% of PathFree Technologies Corporation's profit annually, paid out quarterly, for 5 years. With conservative projections, investors can expect a low-end return of 57% annually. In addition, investors have the option to receive a return of capital or convert their units into equity in PathFree Technologies Corporation on a 1-for-1 basis.
A Company with Significant Growth Potential
PathFree Technologies Corporation has significant growth potential in the global medical device market, projected to reach $612 billion by 2025. Our devices are on schedule to receive FDA clearance, paving the way for commercialization in the United States and the global medical community.
Experienced and Proven Management Team
Our management team at PathFree Technologies Corporation consists of experienced industry professionals with a proven track record of success. Accredited investors can have confidence in our company's ability to execute its growth plans.
Join the Revolution of Healthcare Innovation
Investing in PathFree Expansion LLC is a rare opportunity for accredited investors to be part of a company that is changing the world for the better. Our devices have the potential to revolutionize the healthcare industry and offer accredited investors a chance to be part of something groundbreaking.
Strong Patent Portfolio for Competitive Edge
Our devices have already generated a lot of interest in the industry. We have a strong patent portfolio that gives us a competitive edge and significant market potential. Our devices are designed to be more efficient, less invasive, and safer than existing devices.
Expanding Globally with Accessibility in Mind
PathFree Technologies Corporation is committed to ensuring that our devices are accessible to healthcare professionals globally. With investment received from PathFree Expansion LLC, we plan to expand our manufacturing and distribution capabilities to bring these innovative devices to the global market.
Invest in the Future of Healthcare
In conclusion, PathFree Expansion LLC offers accredited investors an exceptional investment opportunity in the Reg D 506(c) Convertible Common Units. With a fixed and consistent return on investment and the option to convert units into equity, investors can benefit from both short-term and long-term gains. The stability and security of investing in a private company like PathFree Expansion LLC offer a more predictable and profitable investment option.
Investment Plan for the Future
PathFree Technologies is seeking $10,000,000 in capital to manufacture the PathFree AiCart. The funds will be allocated as follows: 50% for Manufacturing and Operations, 20% for Marketing and Sales, 15% for Research and Development, 10% for General and Administrative Expenses, and 5% for Contingency. Based on market research and financial analysis, PathFree Technologies expects to generate $80 million in revenue by the end of year three, with a net profit margin of 25% with plans to expand into international markets in years 4 and 5.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam